Nutrien - NTR Stock Forecast, Price & News

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" NTR shares.
View NTR analyst ratings or view top-rated stocks.

18 brokerages have issued 12-month price targets for Nutrien's shares. Their NTR share price forecasts range from $70.00 to $135.00. On average, they expect the company's share price to reach $105.33 in the next year. This suggests a possible upside of 14.9% from the stock's current price.
View analysts price targets for NTR or view top-rated stocks among Wall Street analysts.

Nutrien's stock was trading at $75.20 at the start of the year. Since then, NTR shares have increased by 21.9% and is now trading at $91.64.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 7th 2022.
View our NTR earnings forecast.

Nutrien Ltd. (NYSE:NTR) released its quarterly earnings data on Monday, November, 1st. The company reported $1.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.23 by $0.15. The firm earned $6.02 billion during the quarter, compared to analyst estimates of $5.59 billion. Nutrien had a net margin of 19.43% and a trailing twelve-month return on equity of 28.14%. The firm's revenue was up 42.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.23 EPS.

Nutrien announced a quarterly dividend on Friday, August 5th. Investors of record on Friday, September 30th will be paid a dividend of $0.48 per share on Friday, October 14th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.10%. The ex-dividend date of this dividend is Thursday, September 29th.
Read our dividend analysis for NTR.

Nutrien (NYSE:NTR) pays an annual dividend of $1.92 per share and currently has a dividend yield of 2.10%. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 15.53%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, NTR will have a dividend payout ratio of 12.63% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NTR.

Nutrien updated its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided EPS guidance of $15.80-$17.80 for the period, compared to the consensus estimate of $17.04. The company issued revenue guidance of -.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a number of retail and institutional investors. Top institutional shareholders include FMR LLC (4.90%), Price T Rowe Associates Inc. MD (2.60%), Deutsche Bank AG (2.23%), Mackenzie Financial Corp (1.96%), Dodge & Cox (1.85%) and TD Asset Management Inc. (1.51%).

Shares of NTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NTR stock can currently be purchased for approximately $91.64.

Nutrien (NYSE:NTR) has a market capitalization of $49.70 billion and generates $27.71 billion in revenue each year. The company earns $3.15 billion in net income (profit) each year or $12.36 on an earnings per share basis.

The company employs 23,500 workers across the globe.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The official website for the company is www.nutrien.com. The company can be reached via phone at (306) 933-8500, via email at investors@nutrien.com, or via fax at 306-933-8877.